BIBLIOGRAFIA
§ Afessa B, Peters S G Major complications following hematopoietic stem cell transplantation 2006 Seminars in Respiratory and Critical Care Medicine 27:297309.
§ Almyroudis N G, Fuller A, Jakubowski A, Sepkowitz K, Jaffe D, Small T N, Kiehn T E, Pamer E, Papanicolaou G A Pre and postengraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients 2005 Transplant Infectious Disease 7:1117.
§ Almyroudis N G, Jakubowski A, Jaffe D, Sepkowitz K, Pamer E, O’Reilly R J, Papanicolaou G A Predictors for persistent cytomegalovirus reactivation after Tcelldepleted allogeneic hematopoietic stem cell transplantation 2007 Transplant Infectious Disease 9:286294.
§ Altschuler E L, Kast R E The atypical antipsychotic agents ziprasidone, risperidone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy 2005 Medical Hypotheses 65:585
586.
§ Aoudjhane M, Labopin M, Gorin N C, Shimoni A, Ruutu T, Kolb H J, Frassoni F, Boiron J M, Yin J L, Finke J, Shouten H, Blaise D, Falda M, Fauser A A, Esteve J, Polge E, Slavin S, Niederwieser D, Nagler A, Rocha V Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) and the European group for Blood and Marrow Transplantation (EBMT)2005 Leukemia 19:23042312.
§ Auner H W, Zebisch A, Ofner P, Sill H, Linkesch W, Krause R Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases 2005 Annals of Hematology 84:532537.
§ Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab J P, Santucci A, Perruccio K, Martelli M P, Mecucci C, Reisner Y, Martelli M F Full haplotypemismatched hematopoietic stem cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 2005 Journal of Clinical Oncology 23:3477
3454.
§ Baldanti F, Lilleri D, Gerna G Monitoring human Cytomegalovirus infection in transplant recipients 2008 Journal of Clinical Virology 41:237241.
§ Bast R C, Kufe D, Pollock R E, Weichselbaum R R, Holand J F, Frei E Cancer medicine Fifth edition 2000 BC Decker edition Section 18: Principles of Bone Marrow Transplantation.
§ Battiwalla W, Wu Y, Bajwa R P S, Radovic M, Almyroudis N G, Segal B H, Wallace P K, Nakamura R, Padmanabban S, Hahn T, McCarthy P L Gancyclovir inhibits lymphocyte proliferation by impairing DNA synthesis 2007 Biology of Blood and Marrow Transplantation 13:765770.
§ Bethge W A, Schmaizing M, Stuhler G, Schumacher U, Krober S M, Horger M, Einsele H, Kanz L, Hebart H Mucormycoses in patients with hematologic malignancies: an emerging fungal infection 2005 Haematologica 90:e62e64.
§ Boeckh M, Erard V, Zerr D, Englund J Emerging viral infections after hematopoietic cell transplantation 2005 Pediatric Transplantation 9:4854.
§ Boeckh M, Kim H W, Flowers M E D, Meyers J D, Bowden R ALongterm
hematopoietic cell transplantation – a randomized doubleblind placebo
controlled study 2006 Blood 107:18001805.
§ Boeckh M, Leisenring W, Stanley R R, Bowden R A, Huang M L, Myerson D, StevensAyers T, Flowers M E D, Cunningham T, Corey L Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and Tcell immunity 2003 Blood 101:407414.
§ Boeckh M, Nichols W G The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy 2004 Blood 103:20032008.
§ Bonadio M, Morelli G, Mori S, Riccioni R, Papineschi F, Petrini M Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications 2005 Biomedicine and Pharmacotherapy 59:511
516.
§ Bridges B, Donegan S, Badros A Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation 2006 American Journal of Hematology 81:535537.
§ Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi M S, Martinelli G, Allione B, D’Antonio D, Buelli M, Nosari A M, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Lambertenghi Deliliers G, Lauria F, Foà R, Del Favero A, for the Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Infection Program Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia 2005 New England Journal of Medicine 353:977987.
§ Cappellano P, Viscoli C, Bruzzi P, Van Lint M T, Pereira C A, Bacigalupo A Epidemiology and risk factors for bloodstream after allogeneic hematopoietic stem cell transplantation 2007 The New Microbiologica 30:89
§ Castoldi G, Liso V Malattie del sangue e degli organi ematopoietici Quarta edizione 2004 McGraw Hill Capitolo 22: Trapianto di cellule staminali emopoietiche.
§ Center for Diseases Control and Prevention Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients:
recommendations of CDC, the Infectious Diseases Society of America and American Society of Blood and Marrow Transplantation 2000 Morbidity and Mortality Weekly Report 49:1125.
§ Cherif H, Kronvall G, Bjorkholm M, Kalin M Bacteriemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14year period without antibacterial prophylaxis 2003 Hematology Journal 46:420426.
§ Daly A, McAfee S, Dey B, Colby C, Schulte L, Yeap B, Sackstein R, Tarbell N J, Sachs D, Sykes M, Spitzer T R Nonmyeloablative bone marrow transplantation: infectious complications in 65 recipients of HLAidentical and mismatched transplants 2003 Biology of Blood and Marrow Transplantation 9:373382.
§ Diekema D J, Pfaller M A, Schimtz F J, Smayevski J, Bell J, Jones R N, Beach M, and the SENTRY partecipants group Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collacted in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 19971999 2001 Clinical Infectious Diseases 32(Supplemento2):S114S132.
§ Elphick G F, Querbes W, Jordan J A, Gee G V, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze W K, Roth B L, Atwood W J The human polyomavirus, JCV, uses serotonin receptors to infect cells 2004 Science 306:138031383.
§ Elting L S, Rubenstein E B, Rolston K V I, Bodey G P Outcomes of bacteremia in patients with cancer and neutropenica: Observations from two decades of epidemiological and clinical trials 1997 Clinical Infectious Diseases 25:247259.
§ Englund J A, Kuypers J, Nichols G, Hackman R C, Morrow R A, Fredricks D N, Corey L Fatal human Metapneumovirus infection in stem cell transplant recipients 2006 Annals of Internal Medicine 144:344349.
§ Erard V, Storer B, Corey L, Nollkamper J, Huang M L, Limaye A, Boeckh M BK virus infection in hematopoietic stem cell transplant recipients:
frequency, risk factors and association with postengraftment hemorrhagic cystitis 2004 Clinical Infectious Diseases 39:18611865.
§ Erard V, Kim H W, Corey L, Limaye A, Huang M L, Myerson D, Davis C, Boeckh M BK DNA viral load in plasma: evidence for an association with haemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients 2005 Blood 106:11301132.
§ Fefer A, Sullivan K M, Weiden P, Buckner C D, Schoch G, Storb R, Thomas E D Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation 1987 Progress in Clinical and Biological Research 244:401408.
§ Focosi D, Fazzi R, Montanaro D, Emdin M, Petrini M Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipients: a clinical, neuroradiological and virological response after treatment with risperidone 2007 Antiviral Research 74:156158.
§ Garbino J, Romand J A, Pitter D, Giostra E, Mentha G, Suter P Infection and rejection in liver transplant patients: a 10year Swiss single center experience 2005 Swiss Medical Weekly 135:578593.
§ Gerna G, Baldanti F, Torsellini M, Minoli L, Viganò M, Oggionni T, Rampino T, Castiglioni B, Goglio A, Colledan M, Mammana C, Nozza F, Lilleri D Evaluation of cytomegalovirus DNAemia versus pp65antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study 2007 Antiviral Therapy 12:6372.
§ Gerna G, Lilleri D, Zecca M, Alessandrino E P, Baldanti F, Revello M G, Locatelli F Rising antigenemia levels may be misleading in preemptive therapy of human Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients 2005 Haematologica 90:526533.
§ Gerna G, Lilleri D Monitoring transplant patients for human Cytomegalovirus: diagnostic update 2006 Herpes 13:411.
§ Ghosh S, Champlin R E, Englund J, Giralt S A, Rolston K, Raad I, Jacobson K, Neumann J, Ippoliti C, Mallik S, Whimbey E Respiratory syncytial virus upper respiratory tract illness in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin 2000 Bone Marrow Transplantation 25:751755.
§ Gilbert D N, Moellering R C, Eliopoulos G M, Sande M A Guida Sanford alla terapia antimicrobica 2004 34° edizione.
§ Girmenia C, Pagano L, Martino B, D’Antonio D, Fanci R, Specchia G, Melillo L, Buelli M, Pizzarelli G, Venditti M, Martino P, the GINEMA Infection Program Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multi center study from Italy an review of the literature 2005 Journal of Clinical Microbiology 43:18181828.
§ Glucksberg H, Scorb R, Fefer A Clinical manifestations of GvHD in human recipients of marrow from HLAmatched sibling donors 1974 Transplantation 18:295304.
§ Gorak E J, Yamada S M, Brown J D Communityacquired methicillin
resistant Staphylococcus aureus in hospitalized adults and children without known risk factors 1999 Clinical Infectious Diseases 29:797800.
§ Gottschalk S, Rooney C M, Heslop H E PostTransplant Lymphoproliferative Disorders 2005 Annual Review of Medicine 56:2944.
§ Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P, Einsele H, Cordonnier C for the Acute and Chronic Leukemia Working Parties and the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time 2005 Bone Marrow Transplantation 36:751769.
§ Hachem R Y, Chemaly R F, Ahmar C A, Jiang Y, Boktour M R, Rjaili G A, Bodey G P, Raad I I Colistin is effective in treatment of infections caused by multidrugresistance Pseudomonas aeruginosa in cancer patients 2007 Antimicrobial Agents and Chemotherapy 51:19051911.
§ Hakki M, Limaye A P, Kim H W, Kirby K A, Corey L, Boeckh M Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation 2007 Bone Marrow Transplantation 39:687693.
§ Heemskerk B, Lankester A C, van Vreeswijk T, Beersma M F C, Claas E C J, Veltrop Duits L A, Kroes A C M, Vossen J M J J, Schilham M W, van Tol M J D Immune reconstitution and clearance of human Adenovirus viremia in pediatric stemcell recipients 2005 The Journal of Infectious Diseases 191:520
530.
§ Hughes W T, Armstrong D, Bodey G P, Bow E J, Brown A E, Calandra T, Feld R, Pizzo P A, Rolston K V I, Shenep J L, Young L S Guidelines for the
use of antimicrobial agents in neutropenic patients with cancer 2002 Clinical Infectious Diseases 34:730751.
§ Jillella A P, Ustun C, Robach E, Sertkaya D, DiPiro C, Kallab A M, Brick W G, Dainer P M, Kutlar A, Townsend A R, Burgess R E Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection 2003 Journal of Hematotherapy and Stem Cell Research 12:155160.
§ Junghanss C, Marr K A, Carter R A, Sandmaier B M, Maris M B, Maloney D G, Chauncey T, McSweeney P A, Storb R Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study 2002 Biology of Blood and Marrow Transplantation 8:512520.
§ Kahan B D, Rajagopalan P R, Hall M Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric antiinterleukin2receptor monoclonal antibody. United States Simulect Renal Study Group 1999 Transplantation 67:276284.
§ Kern W V, Klose K, JellenRitter A S Fluroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia 2005 European Journal Clinical Microbiology Infectious Diseases 24:111118.
§ Kim D H, Messner H, Minden M, Gupta V, Kuruvilla J, Wright J, Lipton J Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: lowdose acyclovir prophylaxis and pre
transplant diagnosis of lymphoproliferative disorders 2008 Transplant Infectious Disease 10:9098.
§ Kirkpatrick B D, Harrington S M, Smith D An outbreack of vancomycin
dependent Enterococcus faecium in a bone marrow transplant unit 1999 Clinical Infectious Diseases 29:12681273.
§ Koc Y, Miller K B, Schenkein D P, Griffith J, Akhtar M, DesJardin J, Snydman D R Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors and clinical outcome 2000 Biology of Blood and Marrow Transplantation 6:4449.
§ Kollman C, Howe C W, Anasetti C, Antin J H, Davies S M, Filipovich A H, Hegland J, Kamani N, Kernan N A, King R, Ratanatharathorn V, Weisdorf C, Confer D L Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age 2001 Blood 98:20432051.
§ Kruger W, Russmann B, Kroger N, Salomon C, Ekopf N, Elsner H A, Kaulfers P M, Mack D, Fuch N, Durken M, Kabishi H, Erttmann R, Zander A R Early infections in patients undergoing bone marrow or blood stem cell transplantation: a 7 year single centre investigation of 409 cases 1999 Bone Marrow Transplantation 23:589597.
§ Lankester A C, Heemskerk B, Claas E C J, Schilham M W, Beersma M F C, Bredius R G M, van Tol M J D, Kroes A C M Effect of Ribavirin on the plasma viral DNA load in patients with disseminating Adenovirus infection 2004 Clinical Infectious Diseases 38:15211525.
§ Lankester A C, van Tol M J D, Claas E C J, Vossen J M, Kroes A C M Quantification of Adenovirus DNA in plasma for management of infection in stem cell graft recipients 2002 Clinical Infectious Diseases 34:864867.
§ La Placa M Principi di Microbiologia Medica2002 Esculapio Editore.
§ Leen A M, Rooney C M Adenovirus as an emerging pathogen in immunocompromised patients 2004 British Journal of Haematology 128:135
144.
§ LereuzVille M, Minard V, Lacaille F, Buzyn A, Abachin E, Blanche S, Freymuth F, Rouzioux C RealTime blood plasma Polymerase Chain Reaction for management of disseminated Adenovirus infection 2004 Clinical Infectious Diseases 38:4552.
§ Leung A Y, Suen C K, Lie A K, Liang R H, Yuen K Y, Kwong Y L Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation 2001 Blood 98:19711978.
§ Lion T, Baumgartinger R, Watzinger F, Matthes Martin S, Suda M, Preuner S, Futterknecht B, Lawitschka A, Peters C, Potschger U, Gadner H Molecular monitoring of Adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease 2003 Blood 102:11141120.
§ Ljungman P Prevention and treatment of viral infections in stem cell transplant recipients 2002 British Journal of Haematology 118:4457.
§ Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C Donor CMV serological status and outcome of CMV seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis 2003 Blood 102:42554260.
§ Ljungman P, Griffiths P, Paya C Definitions of Cytomegalovirus infection and disease in transplant recipients 2002 Clinical Infectious Diseases 34:1094
1097.
§ Ljungman P, Reusser P, de la Camara R, Einsele H, Engelhard D, Ribaud P, Ward K, Cordonnier C for the Infectious Diseases Working Party of the
infections: recommendations from the infectious diseases working party of the EBMT2004 Bone Marrow Transplantation 33:10751081.
§ Locasciulli A, Bruno B, Alessandrino E P, Meloni G, Arcese W, Bandini G, Cassibba V, Rotoli B, Morra E, Majolino I, Alberti A, Bacigalupo A, Italian Cooperative Group for Blood and Marrow Transplantation Hepatitis reactivation and liver failure in haematopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian Group for Blood and Marrow Transplantation 2003 Bone Marrow Transplantation 31:295300.
§ Locasciulli A, Testa M, Valsecchi M G, Bacigalupo A, Solinas S, Tomas J F, Ljungman P, Alberti A The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group 1999 Transplantation 68:14861491.
§ Luppi M, Barozzi P, Schulz T F, Setti G, Staskus K, Trovato R, Narni F, Donelli A, Maiorana A, Marasca R, Sandrini S, Torelli G Bone marrow failure associated with human herpesvirus 8 infection after transplantation 2000 The New England Journal of Medicine 343:13781385.
§ Luppi M, Trovato R, Barozzi P, Gibellini F, Potenza L, Riva G, Torelli G Suppressive effect of human herpesvirus8/Kaposi sarcomaassociated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 2005 Leukemia Research 29:951953.
§ Mandell G L, Bennett J E, Dolin R Principles and practise of Infectious Disease Sixth edition 2005 Elsevier Churchill Livingstone.
§ Marena C, Zecca M, Carenini M L, Bruschi A, Bassi M L, Olivieri P, Azzaretti S, Locatelli F Incidence of, and risk factor for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on
procedurerelated mortality 2001 Infection Control and Hospital Epidemiology 22:510517.
§ Martino R, Bretagne S, Rovira M, Ullmann A J, Maertens J, Held T, Deconinck E, Cordonnier C on behalf of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation Toxoplasmosis after hematopoietic stem transplantation. Report of a 5year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation 2000 Bone Marrow Transplantation 25:11111114.
§ Martino R, Rovira M, Carreras E, Solano C, Sierra J, De la Rubia J, Caballero M D, de Oteyza J P, Zuazu J, Moraleda J M, Ojeda E, Ferrà C, Serrano D, De la Camara R, UrbanoIspizua A, Brunet S, for the alloPBSCT and Infectious/Noninfectious complications subcommittees of the Grupo Espanol de Transplante Hematopoyetico (GETH) Severe infections after allogeneic peripheral blood stem cell transplantation: a matched pair comparison of unmanipulated and CD34+ cellselected transplantation 2001 Haematologica 86:10751086.
§ Marty F M, Rubin R H The prevention of infection posttransplant: the role of prophylaxis, preemptive and empiric therapy 2005 Transplant International 19:211.
§ Meijer E, Dekker A W, Lokhorst H M, Petersen E J, Nieuwenhuis H K, Verdonck L F Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation 2004 Transplant Infectious Disease 6:171178.
§ Mossad S B, Longworth D L, Goormastic M, Serkey J M, Keys T F, Bolwell B J Early infectious complications in autologous bone marrow transplantation: a review of 219 patients 1996 Bone Marrow Transplantation 18:265271.
§ Nashan B, Light S, Hardie I R, Lin A, Johnson J R Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group 1999 Transplantation 67:110115.
§ Neyts J, De Clercq E Mycophenolate mofetil strongly potentiates the anti
herpesvirus activity of acyclovir 1998 Antiviral Research 40:5356.
§ Nimmo G R, Bell J M, Mitchell D, Gosbell I B, Pearman J W, Turnidge J D Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 19891999 2003 Microbial Drug Resistance 9:155160.
§ Novitzky N, Rouskova A Infectious complications following Tcell depleted hematopoietic stem cell transplantation 2001 Cytotherapy 3:165173.
§ Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A, Manso E, Montanari M, Centurioni R, Leoni P Infectious complications after autologous peripheral blood progenitor cell transplantation followed by GCSF 1999 Bone Marrow Transplantation 24:10791087.
§ Oz H S, Hughes W T Novel antiPneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone 1997 Journal Infectious Diseases 175:901904.
§ Pelosini M, Focosi D, Fazzi R, Galimberti S, Caracciolo F, Benedetti E, Papineschi F, Petrini M Progressive multifocal leukoencephalopathy: report of three cases in HIVnegative hematological patients and review of literature 2008 Annals of Hematology 87:405412.
§ Poutsiaka D D, Price L L, Ucuzian A, Chan G W, Miller K B, Snydman D R Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality 2007 Bone Marrow Transplantation 40:63
70.
§ Przepiorka D, Weisdorf D, Martin P, Klingemann H G, Beatty P, Hows J, Thomas E D 1994 Consensus Conference on Acute GVHD Grading 1995 Bone Marrow Transplantation 156:825828.
§ Puig N, de la Rubia J, Jarque I, Salavert M, Montesinos P, Sanz J, Martin G, Sanz G, Cantero S, Lorenzo I, Sanz M A A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation 2007 Internal Journal of Hematology 86:186192.
§ Razonable R R, Paya C V Infections and allograft rejectionintertwined complications of organ transplantation 2005 Swiss Medical Weekly 135:571
573.
§ Reich G, Mapara M Y, Reichardt P, Dorken B, Maschmeyer G Infectious complications after highdose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors 2001 Bone Marrow Transplantation 27:525529.
§ Reuter S, Kern W V, Sigge A Impact of fluoroquinolone prophylaxis on reduced infectionrelated mortality among patients with neutropenia and hematologic malignancies 2005 Clinical Infectious Diseases 40:10871093.
§ Robin M, Porcher R, De Castro A R, de Latour R P, Devergie A, Rocha V, Larghero J, Ades L, Ribaud P, Mary J Y, Socie G Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor 2007 Biology of Blood and Marrow Transplantation 13:13041312.
§ Rolston K V I Challenges in the treatment of infections caused by Gram
positive and Gramnegative bacteria in patients with cancer and neutropenia 2005 Clinical Infectious Diseases 40:S246S252.
§ Rolston K V I, Yadegarynia D, Kontoyiannis D P, Raad I I, Ho D H The spectrum of Grampositive bloodstream infections in patients with hematologic malignancies and the in vitro activity of various quinolones against Gram
positive bacteria isolated from cancer patients 2006 International Journal for Infectious Diseases 10:223230.
§ Safdar A, Rodriguez G, Rolston K V I, O’Brien S, Khouri I F, Shpall E J, Keating M J, Kantarjian H M, Champlin R E, Raad I I, Kontoyiannis D P Highdose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation 2007 Bone Marrow Transplantation 39:157164.
§ Seidemann K, Heim A, Pfister E D, Koditz H, Beilken A, Sander A, Melter M, Sykora K W, Sasse M, Wessel A Monitoring of Adenovirus infection in pedriatic transplant recipients by quantitative PCR: Report of six cases and review of the literature 2004 American Journal of Transplantation 4:2102
2108.
§ Sieradzki K, Roberts R B, Haber S W, Tomasz A The development of vancomycin resistance in a patient with methicillinresistant Staphylococcus aureus infection 1999 New England Journal Medicine 340:517523.
§ Singh N Interactions between viruses in transplant recipients 2005 Clinical Infectious Diseases 40:430436.
§ Small T N, Casson A, Malak S F, Boulad F, Kiehn T E, Stiles J, Ushay H M, Sepkowitz K A Respiratory syncytial virus infection following hematopoietic stem cell transplantation 2002 Bone Marrow Transplantation 29:321327.
§ Stevens S J, Verschuuren E A, Pronk I, van der Bij W, Harmsen M C, Hauw The T, Meijer C J L M, van del Brule A J C, Middeldorp J M Frequent monitoring of EpsteinBarr virus DNA load in unfractionated whole blood in
essential for early detection of posttrasplant lymphoproliferative disease in high risk patients 2001 Blood 97:11651171.
§ Sullivan K M, Dykewicz C A, Longworth D L, Boeckh M, Baden L R, Rubin R H, Sepkowitz K A Preventing opportunistic infections after hematopoietic stem cell transplantation: the Center for Disease Control and Prevention, Infectious Diseases Society of America and American Society for Blood and Marrow Transplantation Practise Guidelines and Beyond 2001 Hematology 1:392421.
§ Sullivan K M, Fefer A, Witherspoon R, Storb R, Buckner C D, Weiden P, Schoch G, Thomas E D GraftversusLeukemia in man: relationship of acute and chronic graftversushost disease to relapse of acute leukemia following allogeneic bone marrow transplantation 1987 Progress in Clinical and Biological Research 244:391399.
§ Thomas N J, Hollenbeak C S, Ceneviva G D, Geskey J M, Young M J Palivizumab prophylaxis to prevent respiratory syncytial virus mortality after pediatric bone marrow transplantation: a decision analysis model 2007 Journal of Pediatric Hematology and Oncology 29:227232.
§ Thomson K J, Hart D P, Banerjee L, Ward K N, Peggs K S, Mackinnon S The effect of lowdose acyclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation 2005 Bone Marrow Transplantation 35:10651069.
§ Timmers G J, SimoonsSmit A M, Leidekker M E, Janssen J J W M, VandenbrouckeGrauls C M J E, Huijgens P C Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with hematological malignancies 2007 Clinical Microbiology and Infection 13:497
503.
§ Toupance O, BouedjoroCamus M C, Carquin J, Novella J L, Lavaud S
recipients: a cohort study with casecontrol analyses 2000 Transplant International 13:413419.
§ Upton A, Kirby K A, Carpenter P, Boeckh M, Marr K A Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and prognostic factors associated with mortality 2007 Clinical Infectious Diseases 44:531540.
§ Van Esser J W, Niesters H G, van der Holt B, Meijer E, Osterhaus A D M E, Gratama J W, Verdonck L F, Lo wenberg B, Cornelissen J J Prevention of EpsteinBarr viruslymphoproliferative disease by molecular monitoring and preemptive rituximab in high risk patients after allogeneic stem cell transplantation 2002 Blood 99:43644369.
§ van Tol M J D, Claas E C J, Heemskerk B, VeltropDuits L A, de Brouwer C S, van Vreeswijk T, Sombroek C C, Kroes A C M, Beersma M F C, de Klerk E P A, Lankester A C, Schilham M W Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity 2005 Bone Marrow Transplantation 35:573576.
§ Wade J C Viral infections in patients with hematological malignancies 2006 Hematology 1:368374.
§ Weisdorf D J, Hurd D, Carter S, Howe C, Jensen L A, Wagner J, Stablein D, Thompson J, Kernan N AProspective grading of GraftversusHost Disease after unrelated donor marrow transplantation: a grading algorithm versus blinded panel review 2003 Biology of Blood and Marrow Transplantation 9:512518.
§ Wisplinghoff H, Seifert H, Wenzel R P, Edmond M B Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States 2003 Clinical Infectious Diseases 36:11031110.
§ Wu H, Pfarr D S, Losonsky G A, Kiener P A Immunoprophylaxis of RSV infection: advancing from RSVIGIV to palivizumab and motavizumab 2008 Current Topics in Microbiology and Immunology 317:103123.
§ Yadegarynia D, Tarrand J, Raad I I, Rolston K V I Current spectrum of bacterial infections in cancer patients 2003 Clinical Infectious Diseases 37:11441145.
§ Zerr D M, Corey L, Kim H W, Huang M L, Nguy L, Boeckh M Clinical outcomes of Human Herpesvirus 6 after hematopoietic stem cell transplantation 2005 Clinical Infectious Diseases 40:932940.
§ Zollner Schwetz I, Auner H W, Paulitsch A, Buzina W, Staber P B, Ofner Kopeinig P, Reisinger E C, Olschewski H, Krause R Oral and intestinal Candida colonization in patients undergoing hematopoietic stem cell transplantation 2008 The Journal of Infectious Diseases 198:150153.
